Efficacy and Safety of Telbivudine in Chinese Children and Adolescents with Chronic Hepatitis B

被引：0
|
作者：
Zhang, Hongfei [1 ]
Zhu, Shishu [1 ]
Dong, Yi [1 ]
Wang, Limin [1 ]
Xu, Zhiqiang [1 ]
Chen, Dawei [1 ]
Gan, Yu [1 ]
Wang, Fuchuan [1 ]
机构：
[1] 302 Hosp PLA, Beijing, Peoples R China
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1917
引用
收藏
页码：1123A / 1124A
页数：2
相关论文
共 50 条
  • [41] Telbivudine for chronic hepatitis B: the GLOBE trial
    Yuen, Man-Fung
    Lai, Ching-Lung
    FUTURE VIROLOGY, 2008, 3 (04) : 317 - 323
  • [42] Telbivudine:A new treatment for chronic hepatitis B
    Deepak N Amarapurkar
    World Journal of Gastroenterology, 2007, (46) : 6150 - 6155
  • [43] Telbivudine for the treatment of chronic hepatitis B infection
    Hartwell, D.
    Jones, J.
    Harris, P.
    Cooper, K.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 23 - 30
  • [44] Telbivudine: A new treatment for chronic hepatitis B
    Amarapurkar, Deepak N.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (46) : 6150 - 6155
  • [45] Safety and efficacy of telbivudine for chronic hepatitis B during the entire pregnancy: Long-term follow-up
    Shang, J.
    Wen, Q.
    Wang, C. C.
    Liu, K.
    Bai, L.
    Tang, H.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 : 43 - 48
  • [46] Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience
    Tsai, M. -C.
    Chen, C. -H.
    Tseng, P. -L.
    Hung, C. -H.
    Chiu, K. -W.
    Wang, J. -H.
    Lu, S. -N.
    Lee, C. -M.
    Chang, K. -C.
    Yen, Y. -H.
    Lin, M. -T.
    Chou, Y. -P.
    Hu, T. -H.
    CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (01) : 95.e1 - 95.e7
  • [47] EFFICACY AND SAFETY OF TELBIVUDINE USE IN HIGHLY VIREMIC MOTHERS WITH HBEAG plus CHRONIC HEPATITIS B (CHB) IN CLINICAL PRACTICE
    Han, G.
    Jiang, H.
    Zhao, W.
    Ge, C.
    Xu, C.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S202 - S202
  • [48] Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (Age 2 to < 18 years) with chronic hepatitis B
    Jonas, Maureen M.
    Kelly, Deirdre
    Pollack, Henry
    Mizerski, Jacek
    Sorbel, Jeff
    Frederick, David
    Mondou, Elsa
    Rousseau, Franck
    Sokal, Etienne
    HEPATOLOGY, 2008, 47 (06) : 1863 - 1871
  • [49] Durability of efficacy after telbivudine off-treatment in chronic hepatitis B patients
    Chen Da-biao
    Chen You-ming
    Liu Jing
    Xie Dong-ying
    Lu Cui-rong
    Huang Zhan-lian
    Zhu Rui-hua
    Gao Zhi-liang
    JOURNAL OF CLINICAL VIROLOGY, 2014, 59 (01) : 50 - 54
  • [50] Efficacy and Safety of Pegylated Interferon for the Treatment of Chronic Hepatitis B in Children and Adolescents A Systematic Review and Meta-analysis
    He, Yi
    Yin, Jingyang
    Xu, Hongmei
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2020, 39 (12) : 1121 - 1126
12345